🦺Medically Written & ReviewedBy Dr. Ajit Kumar, MD (Medicine) — Lifetime Member, Indian Medical Association. About the Author | Editorial Policy Weight loss surgery dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason […]
Evidence-based coverage of weight loss drugs, GLP-1 science, metabolic health, and fat loss strategies. Includes the latest research on Ozempic, Mounjaro, Wegovy, tirzepatide, and semaglutide — reviewed by Dr. Ajit Kumar, MD (Medicine) | MA Psychology.
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an oral version […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: significant muscle […]
Survodutide’s phase 3 results are in. Here is how its real weight-loss and fatty liver (MASLD) data compare to Ozempic and Zepbound — and what is still unapproved, including in India.
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Patients regularly ask me whether there’s a way to get some of what Ozempic does without a prescription. The honest answer is: partially, yes, and it’s worth understanding why — but I want to be upfront […]
